Bankrupt Diomed eyes sale to biolitec
This article was originally published in Clinica
Executive Summary
Manufacturer of minimally-invasive medical technologies Diomed Holdings, which has filed for bankruptcy in the US, is aiming to continue operations by selling some of its assets to German company biolitec. The two firms have entered a non-binding letter of intent for the sale of undisclosed Diomed operating assets for price of $6-7m.